e-learning
resources
ERJ
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Navigating the uncharted waters of combination therapy in pulmonary arterial hypertension: COMPASS or dead-reckoning
Vachiery Jean-Luc, Rubin Lewis J.
Source:
Eur Respir J 2015; 46: 297-298
Journal Issue:
August
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Vachiery Jean-Luc, Rubin Lewis J.. Navigating the uncharted waters of combination therapy in pulmonary arterial hypertension: COMPASS or dead-reckoning. Eur Respir J 2015; 46: 297-298
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
ERS statement on chronic thromboembolic pulmonary hypertension
COVID-19 and the pulmonary circulation
Related content which might interest you:
Pulmonary arterial hypertension: combination therapy in the modern management era
Source: Eur Respir Rev 2010 19: 348-349
Year: 2010
Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready?
Source: Eur Respir J 2014; 44: 1404-1407
Year: 2014
Learning to pair therapies and the expanding matrix for pulmonary arterial hypertension: is more better?
Source: Eur Respir J 2006 Oct 01;28(4):683-686
Year: 2006
Applying pharmacogenomics to pulmonary arterial hypertension (PAH): A target-based approach to therapy
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012
Challenges in the diagnosis and treatment of pulmonary arterial hypertension
Source: Eur Respir Rev 2012 21: 313-320
Year: 2012
New horizons in pulmonary arterial hypertension management
Source: Eur Respir Rev 2014; 23: 408-409
Year: 2014
Optimal management of severe pulmonary arterial hypertension
Source: Eur Respir Rev 2011; 20: 254-261
Year: 2011
Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension
Source: Eur Respir Rev, 30 (162) 210161; 10.1183/16000617.0161-2021
Year: 2021
Repurposing benzbromarone for pulmonary arterial hypertension: can channelling the past deliver the therapy of the future?
Source: Eur Respir J, 53 (6) 1900583; 10.1183/13993003.00583-2019
Year: 2019
Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled
Source: Eur Respir Rev, 26 (146) 170093; 10.1183/16000617.0093-2017
Year: 2017
New horizons in pulmonary arterial hypertension therapies
Source: Eur Respir Rev 2013; 22: 503-514
Year: 2013
Pulmonary arterial hypertension: tailoring treatment to risk in the current era
Source: Eur Respir Rev, 26 (146) 170095; 10.1183/16000617.0095-2017
Year: 2017
Upfront triple therapy for pulmonary arterial hypertension: is three a crowd or critical mass?
Source: Eur Respir J 2014; 43: 1556-1559
Year: 2014
Pulmonary arterial hypertension among elderly patients: an emerging problem?
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007
Combination therapy for pulmonary arterial hypertension: still more questions than answers
Source: Eur Respir J 2004; 24: 339-340
Year: 2004
Optimising the management of pulmonary arterial hypertension patients: emergency treatments
Source: Eur Respir Rev 2010 19: 204-211
Year: 2010
Initial dual oral combination therapy for pulmonary arterial hypertension (PAH) in daily practice
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
Pulmonary arterial hypertension: treatment options
Source: International Congress 2018 – ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED
Year: 2018
Current medical treatment of pulmonary arterial hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012
Current medical treatment of pulmonary arterial hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept